CHRU Strasbourg - Hôpital Hautepierre

Site:	CHRU Strasbourg - Hôpital Hautepierre
Address:
City:	Strasbourg
State:
Zip:	67098
Country:	France

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (ImadGist)	Recruiting	Not yet activated	Imatinib	NCT02260505
2	Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)	Recruiting	Active	Belzutifan	NCT04924075